Skip to main content
Clinical Trials/NCT02863263
NCT02863263TerminatedNot Applicable

A Pilot Study to Evaluate Efficacy and Safety of Hydrophilic Polyurethane Foam Dressing in Patients With Pressure Ulcer

Mundipharma Pte Ltd.2 sites in 1 country5 target enrollmentStarted: July 29, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
5
Locations
2
Primary Endpoint
Number of Patients With Complete Healing of Ulcer Within 12 Weeks

Study Overview

Brief Summary

This study aims to exploratively assess the efficacy and safety of hydrophilic polyurethane foam dressing (MedifoamⓇ or BetafoamⓇ) in pressure ulcer specifically. The target enrolment is 20 patients, with 10 patients per arm.

Detailed Description

As the primary objective, the percentage of completely healed patients and the time to complete healing will be assessed after applying the study device, MedifoamⓇ or BetafoamⓇ, for 12 weeks to pressure ulcer patients. In addition, the pressure ulcer size reduction rate over 12 weeks will be evaluated.

Patients will make once weekly site visits. There are 14 visits in total, including a screening visit 14 days (maximum) before the baseline visit.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged at least 19 years old as of the consent date
  • Pressure ulcer of National Pressure Ulcer Advisory Panel (NPUAP) Stage III at screening
  • Pressure ulcer size of 3-10 cm2 at screening
  • Written consent provided by the subject or representative

Exclusion Criteria

  • Any study ulcer of NPUAP Stage I, II or IV
  • Diabetic ulcer or venous ulcer (or stasis ulcer)
  • Past history of surgical treatment within 1 year or irradiation at the target pressure ulcer within 1 year
  • Hypersensitivity reaction to this product or povidone iodine
  • Hyperthyroidism or thyroid disorder requiring drug treatment
  • Signs of a current underlying systemic infection (sepsis/bacterial infection/tuberculosis) or cellulitis or osteomyelitis
  • Type 1 diabetes
  • Current malnutrition
  • Heavy smoker: Current smoking level of ≥1 pack (20 cigarettes)/day of tobacco
  • Drug or alcohol addiction
  • Requirement of immune-suppressants during the study, or current chemotherapy or radiotherapy
  • Application of other investigational product/medical device within 1 month prior to the investigational device application
  • Pregnant or breast-feeding women
  • Other renal, hepatic, neurological or immunological disorder that may interfere with the wound healing process, at the discretion of the Investigator

Arms & Interventions

Foam Dressing

Other

Over the course of 12 weeks, dressing is performed twice weekly, but additional dressing changes are allowed, depending on the condition of the pressure ulcer such as excessive exudates on the ulcer. The frequency of dressing change is limited to once daily.

Intervention: Foam Dressing (Device)

Foam Dressing with Povidone Iodine

Other

Over the course of 12 weeks, dressing is performed twice weekly, but additional dressing changes are allowed, depending on the condition of the pressure ulcer such as excessive exudates on the ulcer. The frequency of dressing change is limited to once daily.

Intervention: Foam Dressing with Povidone Iodine (Device)

Outcomes

Primary Outcomes

Number of Patients With Complete Healing of Ulcer Within 12 Weeks

Time Frame: 12 weeks

Complete healing is defined as epithelial tissue covering 100% of the ulcer, with intact dermis and epidermis and without abrasion or ulceration.

Time to Complete Healing of Ulcer Within 12 Weeks as Measured by Number of Days From Baseline

Time Frame: 12 weeks

Complete healing is defined as epithelial tissue covering 100% of the ulcer, with intact dermis and epidermis and without abrasion or ulceration.

Pressure Ulcer Size Measured Using A Ruler at Week 12

Time Frame: Week 12 (Or Last Observation Carried Forward)

The ulcer area (for ulcers without re-epithelization) is measured at each visit after foam dressing application. A photograph of the ulcer is taken and a using a ruler (MediRuleⓇ) is used to measure its length and width to obtain the area in cm2.

Secondary Outcomes

  • Pressure Ulcer Scale for Healing (PUSH) Score Measured Using PUSH Tool Version 3.0 At Week 12(Week 12 (Or Last Observation Carried Forward))
  • Number of Participants With a Dressing Change Frequency Greater Than Twice Per Week(12 weeks)
  • Number of Patients Achieving Early Study Completion Due to Complete Healing(12 weeks)
  • Number of Participants With New Infections at the Pressure Ulcer Based on Clinical Signs and Symptoms Checklist (CCSC)(12 weeks)

Investigators

Sponsor
Mundipharma Pte Ltd.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials